HONG KONG, July 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody developed by the company. The trial is investigating ivonescimab...
YONGIN, South Korea, Jan. 15, 2025 /PRNewswire/ -- WIRobotics, the company behind the revolutionary wearable mobility solution WIM(We Innovate Mobility), has achieved a major...
BOSTON, Jan. 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, is proud to announce...
JAKARTA, Indonesia, Jan. 15, 2025 /PRNewswire/ -- PT Bank Rakyat Indonesia (Persero) Tbk. (IDX: BBRI) is pleased to announce it will distribute Rp135 per...
GRAPEVINE and DALLAS, Texas, Jan. 15, 2025 /PRNewswire/ -- Nespon Solutions, a Salesforce Summit Partner, is proud to introduce its latest advancements in implementing...
SHANGHAI, Jan. 15, 2025 /PRNewswire/ -- Goodyear is pleased to announce the appointment of Arvind Bhandari as Chairman and Managing Director of Goodyear India, effective...